Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Lymphoma 9Lymphoma, Non-Hodgkin 4HIV Infections 4Acquired Immunodeficiency Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Multi-centric Castleman's Disease 2Sarcoma, Kaposi 1Precancerous Conditions 1Neoplasms 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1Leukemia-Lymphoma, Adult T-Cell 1Hodgkin Disease 1HTLV-I Infections 1Epstein-Barr Virus Infections 1Dendritic Cell Sarcoma, Interdigitating 1Castleman Disease 1Brain Neoplasms 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

Zidovudine 1Methotrexate 1Leucovorin 1Fluconazole 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-Related Opportunistic Infections × Zidovudine × Lymphoid × Clear all
NCT00000723 2021-10-28

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Terminated
45 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡